肝星状细胞
赖氨酰氧化酶
纤维化
细胞外基质
抗坏血酸
肝纤维化
胶原纤维
细胞生物学
生物
化学
病理
医学
解剖
食品科学
作者
Haobo Wang,Qing You,Kang Bei,Huaqing Jing,Zhiyuan Shi,Soňa Křížková,Zbyněk Heger,Vojtěch Adam,Xiaoyuan Chen,Nan Li
标识
DOI:10.1002/adma.202406590
摘要
Abstract Hepatic fibrosis progresses concomitantly with a variety of biomechanical alternations, especially increased liver stiffness. These biomechanical alterations have long been considered as pathological consequences. Recently, growing evidence proposes that these alternations result in the fibrotic biomechanical microenvironment, which drives the activation of hepatic stellate cells (HSCs). Here, an inorganic ascorbic acid‐oxidase (AAO) mimicking nanozyme loaded with liquiritigenin (LQ) is developed to trigger remodeling of the fibrotic biomechanical microenvironment. The AAO mimicking nanozyme is able to consume intracellular ascorbic acid, thereby impeding collagen I deposition by reducing its availability. Simultaneously, LQ inhibits the transcription of lysyl oxidase like 2 (LOXL2), thus impeding collagen I crosslinking. Through its synergistic activities, the prepared nanosystem efficiently restores the fibrotic biomechanical microenvironment to a near‐normal physiological condition, promoting the quiescence of HSCs and regression of fibrosis. This strategy of remodeling the fibrotic biomechanical microenvironment, akin to “pulling the rug out from under”, effectively treats hepatic fibrosis in mice, thereby highlighting the importance of tissue biomechanics and providing a potential approach to improve hepatic fibrosis treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI